pharma · Diabetic Macular Edema · Non-infectious Uveitis Affecting the Posterior Segment of the Eye · ANIP
ANI PHARMACEUTICALS
ANI PHARMACEUTICALS INC
ANI PHARMACEUTICALS trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
500 Alexander Park, Princeton, New Jersey 08540, US HQ
678 Employees
Public company Type
ANIP · NYSE Ticker
Company details
- Status
- Public
- HQ
- 500 Alexander Park, Princeton, New Jersey 08540, US
- Employees
- 678
- Programs
- 11
- Drugs
- 7
- Patents
- 7
ANI PHARMACEUTICALS clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to ANI PHARMACEUTICALS programs — each row shows trial ID, program name, phase, status, and indication.
ANI PHARMACEUTICALS trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for ANI PHARMACEUTICALS.
-
ILUVIEN — Approved
Clinical update -
Iluvien 0.19 MG Drug Implant — Approved
Clinical update -
ILUVIEN 0.19 MG — Approved
Clinical update -
Fluocinolone Acetonide — Phase 2
Clinical update -
Fluocinolone Acetonide Intravitreal Implant 0.18 mg — Approved
Clinical update -
fluocinolone acetonide — Phase 3
Clinical update -
Fluocinolone Acetonide — Phase 2
Clinical update -
fluocinolone acetonide 190 micrograms — Approved
Clinical update